Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation
- PMID: 29532444
- DOI: 10.1007/s12640-018-9878-2
Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation
Erratum in
-
Correction to: Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase Independent Pathway, Poly [ADP-ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.Neurotox Res. 2022 Apr;40(2):687. doi: 10.1007/s12640-022-00471-0. Neurotox Res. 2022. PMID: 35032303 No abstract available.
Abstract
Piracetam, a nootropic drug, has been clinically used for decades; however, its mechanism of action still remains enigmatic. The present study was undertaken to evaluate the role of mitochondrion-specific factors of caspase-independent pathway like apoptotic-inducing factor (AIF) and endonuclease-G (endo-G) in piracetam-induced neuroprotection. N2A cells treated with lipopolysaccharide (LPS) exhibited significant cytotoxicity, impaired mitochondrial activity, and reactive oxygen species generation which was significantly attenuated with piracetam co-treatment. Cells co-treated with LPS and piracetam exhibited significant uptake of piracetam in comparison to only piracetam-treated cells as estimated by liquid chromatography-mass spectrometry (LC-MSMS). LPS treatment caused significant translocation of AIF and endonuclease-G in neuronal N2A cells which were significantly attenuated with piracetam co-treatment. Significant over-expression of proinflammatory cytokines was also observed after treatment of LPS to cells which was inhibited with piracetam co-treatment demonstrating its anti-inflammatory property. LPS-treated cells exhibited significant oxidative DNA fragmentation and poly [ADP-ribose] polymerase-1 (PARP-1) up-regulation in nucleus, both of which were attenuated with piracetam treatment. Antioxidant melatonin but not z-VAD offered the inhibited LPS-induced DNA fragmentation indicating the involvement of oxidative DNA fragmentation. Further, we did not observe the altered caspase-3 level after LPS treatment initially while at a later time point, significantly augmented level of caspase-3 was observed which was not inhibited with piracetam treatment. In total, our findings indicate the interference of piracetam in mitochondrion-mediated caspase-independent pathway, as well as its anti-inflammatory and antioxidative properties. Graphical Abstract Graphical abstract indicating the novel interference of metabolic enhancer piracetam (P) in neuronal death mechanisms.
Keywords: Apoptosis-inducing factor (AIF); DNA fragmentation; Endonuclease-G; Lipopolysaccharide; Piracetam; Poly (ADP-ribose) polymerase-1 (PARP-1).
Similar articles
-
New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis.Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2078-2096. doi: 10.1016/j.bbadis.2018.03.014. Epub 2018 Mar 16. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29551729
-
The metabolic enhancer piracetam attenuates mitochondrion-specific endonuclease G translocation and oxidative DNA fragmentation.Free Radic Biol Med. 2014 Aug;73:278-90. doi: 10.1016/j.freeradbiomed.2014.05.014. Epub 2014 May 29. Free Radic Biol Med. 2014. PMID: 24882422
-
Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia.Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R215-21. doi: 10.1152/ajpregu.00747.2009. Epub 2010 Apr 28. Am J Physiol Regul Integr Comp Physiol. 2010. PMID: 20427721 Free PMC article.
-
Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion.Free Radic Biol Med. 2005 Jul 1;39(1):81-90. doi: 10.1016/j.freeradbiomed.2005.03.021. Epub 2005 Apr 8. Free Radic Biol Med. 2005. PMID: 15925280 Review.
-
Deadly conversations: nuclear-mitochondrial cross-talk.J Bioenerg Biomembr. 2004 Aug;36(4):287-94. doi: 10.1023/B:JOBB.0000041755.22613.8d. J Bioenerg Biomembr. 2004. PMID: 15377859 Review.
Cited by
-
Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats.Pharmaceuticals (Basel). 2022 Dec 14;15(12):1563. doi: 10.3390/ph15121563. Pharmaceuticals (Basel). 2022. PMID: 36559014 Free PMC article.
-
Dynamic study into autophagy and apoptosis during orthodontic tooth movement.Exp Ther Med. 2021 May;21(5):430. doi: 10.3892/etm.2021.9847. Epub 2021 Feb 26. Exp Ther Med. 2021. PMID: 33747169 Free PMC article.
-
A Novel NOX Inhibitor Alleviates Parkinson's Disease Pathology in PFF-Injected Mice.Int J Mol Sci. 2023 Sep 19;24(18):14278. doi: 10.3390/ijms241814278. Int J Mol Sci. 2023. PMID: 37762579 Free PMC article.
-
Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.Molecules. 2021 Sep 2;26(17):5327. doi: 10.3390/molecules26175327. Molecules. 2021. PMID: 34500759 Free PMC article. Review.
-
Neuroprotective effect of piracetam-loaded magnetic chitosan nanoparticles against thiacloprid-induced neurotoxicity in albino rats.Inflammopharmacology. 2023 Apr;31(2):943-965. doi: 10.1007/s10787-023-01151-x. Epub 2023 Feb 6. Inflammopharmacology. 2023. PMID: 36745244 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous